Petersen H J, Nielsen C K, Arrigoni-Martelli E
J Med Chem. 1978 Aug;21(8):773-81. doi: 10.1021/jm00206a011.
A variety of N-alkyl-N'-pyridyl-N"-cyanoguanidines III was prepared as potential bioisosteres of hypotensive N-alkyl-N'-pyridylthioureas Ia. Optimal activity of the N,N'-disubstituted cyanoguanidines III was assoicated with the presence of four to seven carbon branched alkyl and 3- or 4-pyridyl groups. Maximum potency was displayed by N-tert-pentyl-N'-3 pyridyl-N"-cyanoguanidine (20). This compound proved to be 200 times more potent than the corresponding thiourea in hypertensive rats and dogs. In comparison with guancydine, which is the de-3-pyridyl analogue of 20, a 150-fold increase of potency in spontaneously hypertensive rats was obtained with 20 and its tert-butyl analogue 19. The observed activity appears to be due to direct vascular relaxation. On a weight basis compounds 19, 20, 50, and 101 compared favorably with hydralazine.
制备了多种N-烷基-N'-吡啶基-N"-氰基胍III,作为降压药N-烷基-N'-吡啶基硫脲Ia的潜在生物电子等排体。N,N'-二取代氰基胍III的最佳活性与四至七个碳的支链烷基和3-或4-吡啶基的存在有关。N-叔戊基-N'-3-吡啶基-N"-氰基胍(20)表现出最大效力。该化合物在高血压大鼠和犬中比相应的硫脲效力高200倍。与胍西定(20的去3-吡啶基类似物)相比,20及其叔丁基类似物19在自发性高血压大鼠中的效力提高了150倍。观察到的活性似乎是由于直接的血管舒张作用。以重量计,化合物19、20、50和101与肼屈嗪相比具有优势。